Unknown

Dataset Information

Functional and computational identification of a rescue mutation near the active site of an mRNA methyltransferase.


ABSTRACT: RNA-based drugs are an emerging class of therapeutics combining the immense potential of DNA gene-therapy with the absence of genome integration-associated risks. While the synthesis of such molecules is feasible, large scale in vitro production of humanised mRNA remains a biochemical and economical challenge. Human mRNAs possess two post-transcriptional modifications at their 5' end: an inverted methylated guanosine and a unique 2'O-methylation on the ribose of the penultimate nucleotide. One strategy to precisely methylate the 2' oxygen is to use viral mRNA methyltransferases that have evolved to escape the host's cell immunity response following virus infection. However, these enzymes are ill-adapted to industrial processes and suffer from low turnovers. We have investigated the effects

SUBMITTER: Colin PY 

PROVIDER: S-EPMC7736282 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature